🇺🇸 FDA
Pipeline program

A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin.

NN6537-7650

Phase 1 other active

Quick answer

A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin. for Heart Failure is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Heart Failure
Phase
Phase 1
Modality
other
Status
active

Clinical trials